- Discuss the main elements of arterial access of coronary procedures and follow-up treatment by primary care physicians and cardiologists.
- Explain the advances in the treatment of atrial fibrillation with newer anticoagulaNts and left atrial appendage closure devices.
- List the latest development in cardiac rehabilitation that are safe and effective in improving cardiovascular patients' quality of life and reducing morbidity and mortality.
- Describe the effects of comprehensive lifestyle changes, such as diet, exercise and education, on clinical markers that are risk factors for cardiovascular disease.
- Identify basic and advance screening strategies to indentify CVD risk in clinical practice.
Mansoor A. Qureshi, MD, Co-Director Non-Invasive Vascular Lab, Michigan Heart; and Cardiologist, Saint Joseph Mercy Health System, Ann Arbor
Arterial Access of Coronary Procedures and Follow-up Treatment
Shrin Hebsur, MD, Cardiologist, Clinical Cardiac Electrophysiologist, Saint Joseph Mercey Hospital and Michigan Heart, Ypsilanti
Advances in Treatment of Atrial Fibrillation with Newer Anticoagulants and Left Atrial Appendage Closure Devices: Interesting Case Presentations
Frank Smith, MD, Cardiologist, Michigan Heart, Canton
Cardiac Rehab Reimagined: Past, Present, and Future
Junaed Haq, MD, Director of Medical Education, Pontiac General Hospital
Update in Cardiology Disease Prevention
- Define EoE and present the updated 2017 diagnostic guidelines.
- Discuss the epidemiology, pathophysiology and genetics of EoE.
- Identify the clinical symptoms, allergic manifestations, endoscopic and histologic features of EoE.
- List and define the treatments of EoE which include dietary restriction, pharmacologic therapy and esophageal dilation.
- Explain how to manage patients with EoE.
- Discuss ongoing and future research on EoE.
- Describe the importance of vaccinations in patients with autoimmune disease, with autoimmune disease on immunosuppressive therapy, and with chronic inflammatory conditions.
- Apply the current guidelines to pneumococcal and influenza vaccinations and to recognize the clinical settings in which these vaccines are indicated or cotraindicated.
- Identify best practices to optimizing patient assessment and management in Chronic Urticaria.
Haejin Kim, MD, Clinical Assistant Professor, Wayne State University School of Medicine; Senior Staff Allergist, Division of Allergy and Clinical Immunology, Research Scientist, Division of Public Health Sciences, Henry Ford Health System, Detroit
Paneez Khoury, MD, MHSc, Staff Clinician, Allergy and Immunology, NIAID/LPD/Human Eosinophil Section, Bethesda, MD
Updates in Eosinophilic Disorders
Carl B. Lauter, MD, FACP, FIDSA, FAAAAI, Clinical Profession of Medicine, Wayne State University School of Medicine; Professor of Medicine, Oakland University William Beaumont School of Medicine; and Section Head, Allergy and Clinical Immunology Beaumont Hospital, Royal Oak
Use of Vaccines in Immunodeficiency
Luz M. Fonacier, MD, Section Head, Allergy, Training Program Director, Winthrop University Hopsital; Professor of Clinical Medicine, SUNY at Stony Brook School of Medicine, Stoney Brook, NY
Challenging Cases in Chronic Urticaria: Optimizing Patient Assessment and Management
- Identify a practical approach to the acute stroke management and update the audience about recent stroke treatment and stroke prevention guidelines.
- Describe recent quality and practice parameters in seizures and epilepsy and review basic as well as advanced management in epilepsy.
- Explain how to take a history and evaluate a patient with peripheral neuropathy.
- Discuss the need for further testing and guidelines for initiating appropriate treatment.
Maysaa M. Basha, MD, Associate Professor of Neurology, Wayne State University School of Medicine, Detroit
Kumar Rajamani, MD, Associate Professor of Neurology, Wayne State University School of Medicine Detroit
Top Ten Things in Management of Stroke and Cerebovascular Diseases
Rohit Marawar, MD, Assistant Professor of Neurology, Wayne State University School of Medicine, Detroit
Updates in Seizures and Epilepsy - What's New and What's Old (but still valid)
Abbas Jowkar, MD, Assistant Professor of Neurology, Wayne State University School of Medicine, Detroit
Evaluation and Management of Peripheral Neuropathy for the General Practitioner
- Describe evidence-based management of patients presenting to family physicians with typical signs and symptoms of recent onset of rheumatoid arthritis (RA).
- Discuss early rheumatology referral to enhance the early accurate diagnosis of RA and early initiation of DMARD therapy.
- Explain the different ways of collaboration and co-management of RA patients by PCPs and rheumatologists.
- List improved monitoring methods of RA to screen for cardiovascular disease, malignancy, and infection.
- Describe appropriate vaccination of RA patients to reduce the risk of infection.
- Make a diagnosis of gout based on clinical treatment guidelines and recommendations.
- Explain the multisystem complication of gout, particulary cardiovascular and renal disease, and the association of gout with metabolic syndrome.
- Identify how to best utilize current therapies, and evaluate how more potent urate-lowering therapy might benefit the long-term clinical management of gout.
Manveen K. Saluja, MD, Rheumatologist, Beaumont Health System, Troy
Andrew J. Sulich, MD, Assistant Clinical Professor, Oakland University William Beaumont School of Medicine; and Rheumatologist, Shores Rheumatology, Saint Clair Shores Michigan and Saint John Medical Center, Detroit
The Role of the Primary Care Physician in Rheumatic Disease
Bernard R. Rubin, DO, MPH, Rheumatology Fellowship, Program Director, Henry Ford Health System, Detroit
Update on Gout for the Primary Care Physician
Elena Schiopu, MD, Assistant Professor, Rheumatology, Internal Medicine, University of Michigan Medical School, Ann Arbor
Early RA and pre-RA Diagnosis and Management Including RA Prevention Trial